Genetic Influence on Statin Pharmacodynamics
Information source: Ohio State University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hyperlipidemia; Hypercholesterolemia; Dyslipidemia
Phase: N/A
Status: Recruiting
Sponsored by: Ohio State University Official(s) and/or principal investigator(s): Joseph P Kitzmiller, MD PhD, Principal Investigator, Affiliation: Ohio State University
Overall contact: Joseph P Kitzmiller, MD PhD, Phone: (614) 292 8438, Email: joseph.kitzmiller@osumc.edu
Summary
The study intends to investigate whether genetics influence how individuals respond to
statins (clinical outcomes and changes in carotid intimal media thickness)
Clinical Details
Official title: An Observational Study Investigating Genetic Influences on Clinical Outcomes and Change in Carotid Intimal Thickness in Adults Taking Atorvastatin, Simvastatin, or Lovastatin
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: carotid intimal media thickness (CIMT)
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- recently (within past 3 months) started taking atorvastatin, lovastatin, or
simvastatin
Exclusion Criteria:
- concomitant uses of medications, supplements, or OTCs known to interfere with statin
metabolism
Locations and Contacts
Joseph P Kitzmiller, MD PhD, Phone: (614) 292 8438, Email: joseph.kitzmiller@osumc.edu
Ohio State University Medical Center, Columbus, Ohio 43210, United States; Recruiting Joseph P Kitzmiller, MD PhD, Phone: 614-292-8438, Email: joseph.kitzmiller@osumc.edu Joseph P Kitzmiller, MD PhD, Principal Investigator Bhagwan Satiani, MD, Sub-Investigator Michael Go, MD, Sub-Investigator Rebecca Jackson, MD, Sub-Investigator
Additional Information
Starting date: March 2012
Last updated: April 20, 2015
|